Literature DB >> 19960511

Gene identification using true discovery rate degree of association sets and estimates corrected for regression to the mean.

Michael R Crager1.   

Abstract

Analyses intended to identify genes with expression that is associated with some clinical outcome or state are often based on ranked p-values from tests of point null hypotheses of no association. Van de Wiel and Kim take the innovative approach of testing the interval null hypotheses that the degree of association for a gene is less than some value of interest against the alternative that it is greater. Combining this idea with the false discovery rate controlling methods of Storey, Taylor and Siegmund gives a computationally simple way to identify true discovery rate degree of association (TDRDA) sets of genes among which a specified proportion are expected to have an absolute association of a specified degree or more. This leads to a gene ranking method that uses the maximum lower bound degree of association for which each gene belongs to a TDRDA set. Estimates of each gene's actual degree of association with approximate correction for 'selection bias' due to regression to the mean (RM) can be derived using simple bivariate normal theory and Efron and Tibshirani's empirical Bayes approach. For a given data set, all possible TDRDA sets can be displayed along with the gene ranking and the RM-corrected estimates of degree of association in a concise graphical summary.

Mesh:

Substances:

Year:  2010        PMID: 19960511     DOI: 10.1002/sim.3789

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific Mortality.

Authors:  Michael A Brooks; Lewis Thomas; Cristina Magi-Galluzzi; Jianbo Li; Michael R Crager; Ruixiao Lu; John Abran; Tamer Aboushwareb; Eric A Klein
Journal:  JCO Precis Oncol       Date:  2021-02-24

2.  Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue.

Authors:  Dominick Sinicropi; Kunbin Qu; Francois Collin; Michael Crager; Mei-Lan Liu; Robert J Pelham; Mylan Pho; Andrew Dei Rossi; Jennie Jeong; Aaron Scott; Ranjana Ambannavar; Christina Zheng; Raul Mena; Jose Esteban; James Stephans; John Morlan; Joffre Baker
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

3.  Analysis of small-sample clinical genomics studies using multi-parameter shrinkage: application to high-throughput RNA interference screening.

Authors:  Mark A van de Wiel; Renée X de Menezes; Ellen Siebring-van Olst; Victor W van Beusechem
Journal:  BMC Med Genomics       Date:  2013-05-07       Impact factor: 3.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.